Funding
← Back to your selection

Qiming Venture Partners

Activity from announced rounds

Activity in this selectionSeries A
Rounds participated in
3
Confirmed lead rounds
—
3 roles undisclosed
New companies
3
First participation on record · 0 follow-on
Funding in participating rounds
$190.5M
3 disclosed · full round size, not this investor’s share

By stage

Series A3

By primary sector

Biotech2
AI1

By country

China2
Singapore1

Rounds

3 in this selection
Vivacta Biotechnology

Develops in vivo CAR-T cell therapies for cancer and autoimmune diseases

$50MSeries A+
Role not disclosed
ShengShu Technology

Develops multimodal foundation models for video generation and AI productivity

CN¥600MSeries A
Role not disclosed